Baby boomers targeted for Hepatitis C testing

Recently approved drugs make HepC treatment simple and more effective

The diagnosis was a surprise for Claudia Dionne: testing during her yearly check-up revealed hepatitis C. The liver-damaging virus was not causing symptoms but for the 4 million people in the United States with hepatitis C it can lead to liver cirrhosis, liver cancer and is the most common reason people need a liver transplant.

But research is changing what comes next for those who learn their diagnosis early. New drugs – Victrelis, Incivek, Harvoni, Olysio and Sovaldi — make treatment easier and more effective and in November, combination treatment of Sovaldi and Olysio was approved. Interferon-free oral combination therapy is available for almost all types of hepatitis C infection.

Continue reading